From: The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management
Actual mal_ben
Group size
Predicted
Benign
Malignant
13
12
1
(92.31 %)
(7.69 %)
38
2
36
(5.26 %)
(94.74 %)